Elena M Bingham is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds with therapeutic applications. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, Elena has developed 3-Fluorobenzodiazepines and compositions and uses thereof. This patent includes compounds such as 3-fluoro-1,3-dihydro-1-methyl-7-chloro-5-phenyl-2H-1,4-benzodiazepin-2-one, which are useful as tranquilizers, muscle relaxants, and sedatives. Additionally, she has patented Quinazolinone oxides and their use as intermediates for pharmaceuticals. This patent focuses on 1-Methyl-6-substituted-4-phenyl-quinazolin-2-one-3-oxides, which serve as intermediates in the preparation of 3-fluorobenzodiazepines.

Career Highlights

Elena M Bingham is currently employed at E.I. du Pont de Nemours and Company, where she continues to innovate and contribute to the field of pharmaceutical research. Her work is characterized by a commitment to developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout her career, Elena has collaborated with notable colleagues, including William J Middleton and Arthur John Elliott. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Elena M Bingham's contributions to the field of pharmaceuticals through her innovative patents demonstrate her expertise and dedication. Her work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in healthcare.